X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS TTK HEALTHCARE DR. DATSONS LABS/
TTK HEALTHCARE
 
P/E (TTM) x -10.9 22.9 - View Chart
P/BV x 0.2 7.7 2.1% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 DR. DATSONS LABS   TTK HEALTHCARE
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
TTK HEALTHCARE
Mar-14
DR. DATSONS LABS/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs126663 18.9%   
Low Rs31399 7.7%   
Sales per share (Unadj.) Rs133.0535.6 24.8%  
Earnings per share (Unadj.) Rs0.215.9 1.0%  
Cash flow per share (Unadj.) Rs6.620.0 33.0%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs128.8137.6 93.6%  
Shares outstanding (eoy) m31.667.77 407.5%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.61.0 59.3%   
Avg P/E ratio x516.133.3 1,549.3%  
P/CF ratio (eoy) x11.826.5 44.6%  
Price / Book Value ratio x0.63.9 15.7%  
Dividend payout %025.1 0.0%   
Avg Mkt Cap Rs m2,4774,127 60.0%   
No. of employees `000NA1.7 0.0%   
Total wages/salary Rs m56607 9.2%   
Avg. sales/employee Rs ThNM2,436.7-  
Avg. wages/employee Rs ThNM355.2-  
Avg. net profit/employee Rs ThNM72.5-  
INCOME DATA
Net Sales Rs m4,2114,162 101.2%  
Other income Rs m7961 128.6%   
Total revenues Rs m4,2894,223 101.6%   
Gross profit Rs m569197 288.5%  
Depreciation Rs m20432 644.8%   
Interest Rs m43030 1,438.8%   
Profit before tax Rs m13197 6.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m673 8.4%   
Profit after tax Rs m5124 3.9%  
Gross profit margin %13.54.7 285.1%  
Effective tax rate %48.037.0 129.8%   
Net profit margin %0.13.0 3.8%  
BALANCE SHEET DATA
Current assets Rs m6,8521,629 420.7%   
Current liabilities Rs m6,7111,058 634.4%   
Net working cap to sales %3.313.7 24.4%  
Current ratio x1.01.5 66.3%  
Inventory Days Days16130 540.2%  
Debtors Days Days31834 948.1%  
Net fixed assets Rs m3,673556 660.3%   
Share capital Rs m31778 407.5%   
"Free" reserves Rs m3,761878 428.2%   
Net worth Rs m4,0781,069 381.3%   
Long term debt Rs m1,671159 1,052.8%   
Total assets Rs m12,6332,399 526.5%  
Interest coverage x1.07.6 13.6%   
Debt to equity ratio x0.40.1 276.1%  
Sales to assets ratio x0.31.7 19.2%   
Return on assets %3.46.4 53.7%  
Return on equity %0.111.6 1.0%  
Return on capital %7.718.5 41.6%  
Exports to sales %22.90.8 2,896.2%   
Imports to sales %14.31.4 1,020.5%   
Exports (fob) Rs m96433 2,930.1%   
Imports (cif) Rs m60258 1,032.4%   
Fx inflow Rs m96433 2,930.1%   
Fx outflow Rs m60763 960.8%   
Net fx Rs m357-30 -1,178.3%   
CASH FLOW
From Operations Rs m1,345127 1,062.2%  
From Investments Rs m-2,256-146 1,544.9%  
From Financial Activity Rs m-1,20022 -5,478.5%  
Net Cashflow Rs m-2,1113 -84,428.0%  

Share Holding

Indian Promoters % 4.5 65.4 6.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 1.4 5.2 26.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 25.8 364.7%  
Shareholders   20,807 12,723 163.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   DIVIS LABORATORIES  WOCKHARDT LTD.  AUROBINDO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 170 Points Lower, Realty and FMCG Stocks Witness Selling(Closing)

After opening the day on a positive note, share markets in India witnessed volatile trading activity and ended in red.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Hurricanes Threaten Oil Spike, but the Saudis are Selling...(Vivek Kaul's Diary)

Sep 6, 2018

Oil prices are rising and could go even more higher amid rising tensions in Middle East.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS